Rosuvastatin Calcium Tablet, Film Coated
Product Images NDC 50090-7486

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rosuvastatin Calcium (NDC 50090-7486). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500907486)

Rosuvastatin Calcium 10 mg film-coated tablets packaged by A-S Medication Solutions. The label displays product NDC 50090-7486-0, dosage form as film-coated tablet, quantity of 30 tablets, and storage instructions to keep at 68 to 77 degrees Fahrenheit and protect from moisture. Manufacturer information includes A-S Medication Solutions located in Libertyville, Illinois.*

FDA Label Image

Figure 1. Time To First Occurrence Of Major Cardiovascular Events In Jupiter (Rosuvastatin Fig1)

A cumulative incidence line graph comparing Rosuvastatin Calcium (Rosuva) and placebo over 5 years. The x-axis represents years, while the y-axis shows cumulative incidence percentage. Two lines illustrate incidence rates, with Rosuva lower than placebo. A risk table below shows participant numbers for each group over time.*

FDA Label Image

Figure 2. Major Cv Events By Treatment Group In Jupiter (Rosuvastatin Fig2)

A forest plot chart comparing the number of cardiovascular events between Rosuvastatin Calcium 20 mg and placebo groups. It lists event counts, rates per 1000 patient-years, hazard ratios with 95% confidence intervals, and p-values for endpoints including major cardiovascular events, cardiovascular death, nonfatal stroke, nonfatal myocardial infarction, unstable angina hospitalization, and arterial revascularization. The chart visually shows hazard ratios with confidence intervals indicating event risk reductions for most endpoints with Rosuvastatin Calcium.*

FDA Label Image

Figure 3. (Rosuvastatin Fig3)

Box plot comparing percent change from baseline in LDL-C levels for four statins—Rosuvastatin, Atorvastatin, Simvastatin, and Pravastatin—across various doses (mg), with doses labeled beneath each drug name and percent change on the y-axis.*

FDA Label Image

Chemical Structure (Rosuvastatin Str)

Chemical structure of Rosuvastatin Calcium, showing the molecular arrangement including fluorophenyl, sulfonyl, hydroxyl groups, and calcium ion complex as depicted in the image.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.